User profiles for Peter J. Barnes

Peter J Barnes

Imperial College London
Verified email at imperial.ac.uk
Cited by 269839

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary

KF Rabe, S Hurd, A Anzueto, PJ Barnes… - American journal of …, 2007 - atsjournals.org
Chronic obstructive pulmonary disease (COPD) remains a major public health problem. It is
the fourth leading cause of chronic morbidity and mortality in the United States, and is …

Asthma as an axon reflex

PJ Barnes - The lancet, 1986 - Elsevier
… Fuller RW, Dixon CMS, Barnes PJ. The bronchoconstrictor response to inhaled capsaicin
in humans. J Appl Physiol 1985, 85: 1080-84. Proud D, Macglashan DW, Newball HH, …

Chronic obstructive pulmonary disease in non-smokers

SS Salvi, PJ Barnes - The lancet, 2009 - thelancet.com
Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality
worldwide. Tobacco smoking is established as a major risk factor, but emerging evidence …

Chronic obstructive pulmonary disease: molecular and cellularmechanisms

PJ Barnes, SD Shapiro… - European Respiratory …, 2003 - Eur Respiratory Soc
Chronic obstructive pulmonary disease is a leading cause of death and disability, but has
only recently been extensively explored from a cellular and molecular perspective. There is a …

Immunology of asthma and chronic obstructive pulmonary disease

PJ Barnes - Nature Reviews Immunology, 2008 - nature.com
Asthma and chronic obstructive pulmonary disease (COPD) are both obstructive airway
diseases that involve chronic inflammation of the respiratory tract, but the type of inflammation is …

[HTML][HTML] Decreased histone deacetylase activity in chronic obstructive pulmonary disease

…, IM Adcock, JC Hogg, PJ Barnes - … England Journal of …, 2005 - Mass Medical Soc
Background Chronic obstructive pulmonary disease (COPD) is characterized by chronic
airway inflammation that is greater in patients with advanced disease. We asked whether there …

Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary

…, A Anzueto, PJ Barnes, J Bourbeau… - American journal of …, 2017 - atsjournals.org
This Executive Summary of the Global Strategy for the Diagnosis, Management, and Prevention
of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017 report …

Global strategy for asthma management and prevention: GINA executive summary

…, SS Hurd, PJ Barnes, J Bousquet… - European …, 2008 - Eur Respiratory Soc
Asthma is a serious health problem throughout the world. During the past two decades, many
scientific advances have improved our understanding of asthma and ability to manage and …

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary

…, C Vogelmeier, A Anzueto, PJ Barnes… - American journal of …, 2013 - atsjournals.org
Chronic obstructive pulmonary disease (COPD) is a global health problem, and since 2001,
the Global Initiative for Chronic Obstructive Lung Disease (GOLD) has published its strategy …

Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response

…, TT Hansel, ST Holgate, PJ Sterk, PJ Barnes - The Lancet, 2000 - thelancet.com
Background Interleukin-5 (IL-5) is essential for the formation of eosinophils, which are thought
to have a major role in the pathogenesis of asthma and other allergic diseases. We aimed …